{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:47:23Z","timestamp":1791222443127,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dominant optic atrophy (DOA) is the most common hereditary optic neuropathy. Although DOA is caused by mutations in several genes, there are still many cases that have not been diagnosed or misdiagnosed. Herein, we present a large family of 11 patients with DOA. To identify potential pathogenic mutations, whole exome sequencing (WES) was performed on the proband, a 35-year-old woman. WES revealed a novel pathogenic mutation (c.524T&gt;C, p.F175S) in the <jats:italic>AFG3L2<\/jats:italic> intermembrane space domain, rather than in the ATPase domain, which is the hot mutation region associated with most of the previously reported DOA cases. Functional studies on skin fibroblasts generated from patients and HEK293T cells showed that the mutation may impair mitochondrial function and decrease the ability of AFG3L2 protein to enter the mitochondrial inner membrane. In addition, this novel mutation led to protein degradation and reduced the stability of the AFG3L2 protein, which appeared to be associated with the proteasome-ubiquitin pathway.<\/jats:p>","DOI":"10.1038\/s41420-022-01160-9","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:04:02Z","timestamp":1660557842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A novel mutation located in the intermembrane space domain of AFG3L2 causes dominant optic atrophy through decreasing the stability of the encoded protein"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8952-0787","authenticated-orcid":false,"given":"Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingge","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5497-0905","authenticated-orcid":false,"given":"Bo","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","volume":"120","author":"P Yu-Wai-Man","year":"2013","unstructured":"Yu-Wai-Man P, Chinnery PF. Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates. Ophthalmology. 2013;120:1712\u20131712.e1.","journal-title":"Ophthalmology."},{"key":"1160_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.25723","volume":"88","author":"L Caporali","year":"2020","unstructured":"Caporali L, Magri S, Legati A, Del Dotto V, Tagliavini F, Balistreri F, et al. ATPase domain AFG3L2 mutations alter OPA1 processing and cause optic neuropathy. Ann Neurol. 2020;88:18\u201332.","journal-title":"Ann Neurol"},{"key":"1160_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/0002-9394(79)90565-8","volume":"88","author":"PB Johnston","year":"1979","unstructured":"Johnston PB, Gaster RN, Smith VC, Tripathi RC. A clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol. 1979;88:868\u201375.","journal-title":"Am J Ophthalmol"},{"key":"1160_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1326-8-32","volume":"8","author":"MV Alavi","year":"2013","unstructured":"Alavi MV, Fuhrmann N. Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol Neurodegener. 2013;8:32.","journal-title":"Mol Neurodegener"},{"key":"1160_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-46","volume":"7","author":"G Lenaers","year":"2012","unstructured":"Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46.","journal-title":"Orphanet J Rare Dis"},{"key":"1160_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.molcel.2019.06.016","volume":"75","author":"C Puchades","year":"2019","unstructured":"Puchades C, Ding B, Song A, Wiseman RL, Lander GC, Glynn SE. Unique structural features of the mitochondrial AAA+ protease AFG3L2 reveal the molecular basis for activity in health and disease. Mol Cell. 2019;75:1073\u201385e1076.","journal-title":"Mol Cell"},{"key":"1160_CR7","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1021\/acs.biochem.8b00565","volume":"57","author":"B Ding","year":"2018","unstructured":"Ding B, Martin DW, Rampello AJ, Glynn SE. Dissecting substrate specificities of the mitochondrial AFG3L2 protease. Biochemistry 2018;57:4225\u201335.","journal-title":"Biochemistry"},{"key":"1160_CR8","doi-asserted-by":"publisher","first-page":"e1006463","DOI":"10.1371\/journal.pgen.1006463","volume":"12","author":"S Wang","year":"2016","unstructured":"Wang S, Jacquemyn J, Murru S, Martinelli P, Barth E, Langer T, et al. The mitochondrial m-AAA protease prevents demyelination and hair greying. PLoS Genet. 2016;12:e1006463.","journal-title":"PLoS Genet"},{"key":"1160_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-020-00975-w","volume":"8","author":"V Baderna","year":"2020","unstructured":"Baderna V, Schultz J, Kearns LS, Fahey M, Thompson BA, Ruddle JB, et al. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy. Acta Neuropathol Commun. 2020;8:93.","journal-title":"Acta Neuropathol Commun"},{"key":"1160_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3892\/br.2017.987","volume":"7","author":"D Colavito","year":"2017","unstructured":"Colavito D, Maritan V, Suppiej A, Del Giudice E, Mazzarolo M, Miotto S, et al. Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene. Biomed Rep. 2017;7:451\u20134.","journal-title":"Biomed Rep"},{"key":"1160_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ng.544","volume":"42","author":"D Di Bella","year":"2010","unstructured":"Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, et al. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet. 2010;42:313\u201321.","journal-title":"Nat Genet"},{"key":"1160_CR12","doi-asserted-by":"publisher","first-page":"e1002325","DOI":"10.1371\/journal.pgen.1002325","volume":"7","author":"TM Pierson","year":"2011","unstructured":"Pierson TM, Adams D, Bonn F, Martinelli P, Cherukuri PF, Teer JK, et al. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet. 2011;7:e1002325.","journal-title":"PLoS Genet"},{"key":"1160_CR13","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1212\/NXG.0000000000000428","volume":"6","author":"M Charif","year":"2020","unstructured":"Charif M, Chevrollier A, Gueguen N, Bris C, Gouden\u00e8ge D, Desquiret-Dumas V, et al. Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy. Neurol Genet. 2020;6:e428.","journal-title":"Neurol Genet"},{"key":"1160_CR14","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/humu.23658","volume":"39","author":"S Magri","year":"2018","unstructured":"Magri S, Fracasso V, Plumari M, Alfei E, Ghezzi D, Gellera C, et al. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation. Hum Mutat. 2018;39:2060\u201371.","journal-title":"Hum Mutat"},{"key":"1160_CR15","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1016\/j.febslet.2013.09.009","volume":"587","author":"TA Ramelot","year":"2013","unstructured":"Ramelot TA, Yang Y, Sahu ID, Lee HW, Xiao R, Lorigan GA, et al. NMR structure and MD simulations of the AAA protease intermembrane space domain indicates peripheral membrane localization within the hexaoligomer. FEBS Lett. 2013;587:3522\u20138.","journal-title":"FEBS Lett"},{"key":"1160_CR16","doi-asserted-by":"publisher","first-page":"e3000808","DOI":"10.1371\/journal.pbio.3000808","volume":"18","author":"D Ma","year":"2020","unstructured":"Ma D, Zheng B, Liu HL, Zhao YB, Liu X, Zhang XH, et al. Klf5 down-regulation induces vascular senescence through eIF5a depletion and mitochondrial fission. PLoS Biol. 2020;18:e3000808.","journal-title":"PLoS Biol"},{"key":"1160_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1089\/neu.2016.4486","volume":"34","author":"RE von Leden","year":"2017","unstructured":"von Leden RE, Yauger YJ, Khayrullina G, Byrnes KR. Central nervous system injury and nicotinamide adenine dinucleotide phosphate oxidase: oxidative stress and therapeutic targets. J Neurotrauma. 2017;34:755\u201364.","journal-title":"J Neurotrauma"},{"key":"1160_CR18","first-page":"956","volume":"43","author":"C Wang","year":"2019","unstructured":"Wang C, Cai X, Hu W, Li Z, Kong F, Chen X, et al. Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer\u2019s disease. Int J Mol Med. 2019;43:956\u201366.","journal-title":"Int J Mol Med"},{"key":"1160_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05571-y","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu X, Liang X, Lu Y, Zhu L, Fu R, et al. A novel ADOA associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis. Sci Rep. 2017;7:5704.","journal-title":"Sci Rep"},{"key":"1160_CR20","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","volume":"4","author":"W Yarosh","year":"2008","unstructured":"Yarosh W, Monserrate J, Tong JJ, Tse S, Le PK, Nguyen K, et al. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet. 2008;4:e6.","journal-title":"PLoS Genet"},{"key":"1160_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2019.00170","volume":"7","author":"C Li","year":"2019","unstructured":"Li C, Wang X, Li X, Qiu K, Jiao F, Liu Y, et al. Proteasome inhibition activates autophagy-lysosome pathway associated with TFEB dephosphorylation and nuclear translocation. Front Cell Dev Biol. 2019;7:170.","journal-title":"Front Cell Dev Biol"},{"key":"1160_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cr.2018.17","volume":"28","author":"M Patron","year":"2018","unstructured":"Patron M, Sprenger HG, Langer T. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration. Cell Res. 2018;28:296\u2013306.","journal-title":"Cell Res"},{"key":"1160_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molcel.2014.05.025","volume":"55","author":"MC Rodrigo-Brenni","year":"2014","unstructured":"Rodrigo-Brenni MC, Gutierrez E, Hegde RS. Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6. Mol Cell. 2014;55:227\u201337.","journal-title":"Mol Cell"},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/geno.1999.5818","volume":"59","author":"S Banfi","year":"1999","unstructured":"Banfi S, Bassi MT, Andolfi G, Marchitiello A, Zanotta S, Ballabio A, et al. Identification and characterization of AFG3L2, a novel paraplegin-related gene. Genomics. 1999;59:51\u20138.","journal-title":"Genomics."},{"key":"1160_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1128\/MCB.01470-06","volume":"27","author":"M Koppen","year":"2007","unstructured":"Koppen M, Metodiev MD, Casari G, Rugarli EI, Langer T. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol. 2007;27:758\u201367.","journal-title":"Mol Cell Biol"},{"key":"1160_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm3984","volume":"16","author":"PM Quiros","year":"2015","unstructured":"Quiros PM, Langer T, Lopez-Otin C. New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol. 2015;16:345\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1160_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fmolb.2017.00034","volume":"4","author":"SE Glynn","year":"2017","unstructured":"Glynn SE. Multifunctional mitochondrial AAA proteases. Front Mol Biosci. 2017;4:34.","journal-title":"Front Mol Biosci"},{"key":"1160_CR28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1080\/15548627.2016.1274485","volume":"13","author":"C Gretzmeier","year":"2017","unstructured":"Gretzmeier C, Eiselein S, Johnson GR, Engelke R, Nowag H, Zarei M, et al. Degradation of protein translation machinery by amino acid starvation-induced macroautophagy. Autophagy. 2017;13:1064\u201375.","journal-title":"Autophagy."},{"key":"1160_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophage. Autophagy. 2012;8:445\u2013544.","journal-title":"Autophagy."},{"key":"1160_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbamcr.2006.04.003","volume":"1763","author":"A Olichon","year":"2006","unstructured":"Olichon A, Guillou E, Delettre C, Landes T, Arnaun\u00e9-Pelloquin L, Emorine LJ, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta. 2006;1763:500\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"1160_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","volume":"126","author":"C Frezza","year":"2006","unstructured":"Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177\u201389.","journal-title":"Cell."},{"key":"1160_CR32","doi-asserted-by":"publisher","first-page":"634843","DOI":"10.3389\/fcell.2021.634843","volume":"9","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Rui X, Li Y, You Y, Sheng XL, Lei B. Identification of four novel variants and determination of genotype-phenotype correlations for ABCA4 variants associated with inherited retinal degenerations. Front Cell Dev Biol. 2021;9:634843.","journal-title":"Front Cell Dev Biol"},{"key":"1160_CR33","doi-asserted-by":"publisher","first-page":"635424","DOI":"10.3389\/fcell.2021.635424","volume":"9","author":"L Fu","year":"2021","unstructured":"Fu L, Li Y, Yao S, Guo Q, You Y, Zhu X, et al. Autosomal recessive rod-cone dystrophy associated with compound heterozygous variants in ARL3 gene. Front Cell Dev Biol. 2021;9:635424.","journal-title":"Front Cell Dev Biol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01160-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:15:21Z","timestamp":1669302921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01160-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-01160-9","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures of this study adhered to the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Henan Eye Hospital [IRB approval number: HNEECKY-2019 (15); HNEECKY-2019-12-03] and all participants gave written, informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"361"}}